, ,
Presentations this author is a contributor to:
Engineering stabilised neuropeptide receptors to enable structure-based drug design: Studies of neurotensin and relaxin-3 receptors (#57)
3:30 PM
Daniel Scott
ESA/Neuroendocrinology Australasia Symposium - Neuromodulatory control of brain and behaviour - focus on Relaxin-3 (basic)